跳至主要内容
临床试验/JPRN-UMIN000018369
JPRN-UMIN000018369已完成未知

Exploratory study for the efficacy and safety of Yokukansankachimpihange on behavioral and psychological symptoms of dementia (BPSD) in patients with Alzheimer's disease (AD). - The exploratory study of Yokukansankachimpihange on BPSD in patients with AD.

Keio University School of Medicine0 个研究点目标入组 20 人开始时间: 2015年8月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
65years-old 至 89years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Patients with neurological disease to affect the cognitive function except AD. 2) Patients who have local lesion which affected the cognitive function by CT or MRI. 3) Patients with serious diseases such as malignant tumors, or disorder which is not in stable condition. 4) Patient who has an allergy to Kampo medicine. 5) Patients considered inappropriate by the study investigator.

研究者

相似试验